237 related articles for article (PubMed ID: 25294816)
1. Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.
Sung SY; Wu IH; Chuang PH; Petros JA; Wu HC; Zeng HJ; Huang WC; Chung LW; Hsieh CL
Oncotarget; 2014 Oct; 5(20):9911-29. PubMed ID: 25294816
[TBL] [Abstract][Full Text] [Related]
2. Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma.
Hung SC; Wu IH; Hsue SS; Liao CH; Wang HC; Chuang PH; Sung SY; Hsieh CL
Mol Pharm; 2010 Dec; 7(6):2312-23. PubMed ID: 21033655
[TBL] [Abstract][Full Text] [Related]
3. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
4. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
[TBL] [Abstract][Full Text] [Related]
5. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
[TBL] [Abstract][Full Text] [Related]
6. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.
Zhang J; Yang F; Ding Y; Zhen L; Han X; Jiao F; Tang J
Int J Clin Exp Pathol; 2015; 8(8):9240-7. PubMed ID: 26464672
[TBL] [Abstract][Full Text] [Related]
9. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer stem cells through L1CAM suppresses glioma growth.
Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
[TBL] [Abstract][Full Text] [Related]
11. In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.
Liu CM; Hsieh CL; He YC; Lo SJ; Liang JA; Hsieh TF; Josson S; Chung LW; Hung MC; Sung SY
PLoS One; 2013; 8(1):e53795. PubMed ID: 23342005
[TBL] [Abstract][Full Text] [Related]
12. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating
Kim H; Hwang H; Lee H; Hong HJ
Mol Cells; 2017 May; 40(5):363-370. PubMed ID: 28535665
[TBL] [Abstract][Full Text] [Related]
13. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
[No Abstract] [Full Text] [Related]
14. L1 cell adhesion molecule as a therapeutic target in cancer.
Yu X; Yang F; Fu DL; Jin C
Expert Rev Anticancer Ther; 2016; 16(3):359-71. PubMed ID: 26781307
[TBL] [Abstract][Full Text] [Related]
15. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
16. Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.
Schirmer U; Doberstein K; Rupp AK; Bretz NP; Wuttig D; Kiefel H; Breunig C; Fiegl H; Müller-Holzner E; Zeillinger R; Schuster E; Zeimet AG; Sültmann H; Altevogt P
Oncotarget; 2014 Jan; 5(2):462-72. PubMed ID: 24497324
[TBL] [Abstract][Full Text] [Related]
17. [Role and action mechanisms of FZD5 in prostate cancer bone metastasis in mice].
Zhang X; Mo QW
Zhonghua Nan Ke Xue; 2016 Feb; 22(2):128-32. PubMed ID: 26939396
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells.
Schäfer H; Struck B; Feldmann EM; Bergmann F; Grage-Griebenow E; Geismann C; Ehlers S; Altevogt P; Sebens S
Oncogene; 2013 Jan; 32(2):180-9. PubMed ID: 22349829
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression.
Zhang F; Xu Y; Lin J; Pan H; Giuliano AE; Cui X; Cui Y
Breast Cancer Res Treat; 2024 Apr; 204(3):465-474. PubMed ID: 38183514
[TBL] [Abstract][Full Text] [Related]
20. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]